Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-50,859
Closed -$1.15M 206
2021
Q4
$1.15M Buy
50,859
+12,423
+32% +$252K 0.09% 85
2021
Q3
$775K Buy
38,436
+451
+1% +$10.2K 0.06% 107
2021
Q2
$914K Buy
37,985
+2,972
+8% +$71.9K 0.07% 102
2021
Q1
$850K Buy
35,013
+1,345
+4% +$32.2K 0.07% 104
2020
Q4
$781K Sell
33,668
-187
-0.6% -$3.96K 0.06% 84
2020
Q3
$635K Sell
33,855
-3,224
-9% -$56.5K 0.06% 78
2020
Q2
$625K Buy
+37,079
New +$640K 0.06% 82
2020
Q1
Sell
-26,229
Closed -$943K 147
2019
Q4
$943K Sell
26,229
-89
-0.3% -$3.11K 0.09% 76
2019
Q3
$779K Sell
26,318
-1,155
-4% -$36.2K 0.08% 77
2019
Q2
$975K Buy
27,473
+4,232
+18% +$141K 0.11% 60
2019
Q1
$743K Buy
23,241
+3,510
+18% +$99K 0.09% 70
2018
Q4
$390K Sell
19,731
-780
-4% -$20K 0.05% 95
2018
Q3
$553K Sell
20,511
-9,170
-31% -$243K 0.07% 91
2018
Q2
$712K Buy
29,681
+280
+1% +$7.92K 0.1% 62
2018
Q1
$846K Buy
29,401
+2,609
+10% +$80.2K 0.12% 53
2017
Q4
$781K Buy
+26,792
New +$814K 0.13% 49

Other funds holding XRX

Trilogy Capital's XRX Position: Q1 2022 in Review

Trilogy Capital sold out of Xerox (XRX) in Q1 2022, closing a stake of 50,859 shares — an estimated $1.15M sold.

Trilogy Capital first reported a position in XRX in Q4 2017 and held it in 16 quarters. The position peaked at $1.15M in Q4 2021. 324 funds tracked by Wall St. Rank hold XRX as of Q1 2022.

  • Trilogy Capital reported no remaining Xerox position as of Q1 2022 after selling out during the quarter.
  • Trilogy Capital sold 50,859 Xerox shares in Q1 2022, an estimated $1.15M.
  • Trilogy Capital first reported a position in Xerox in Q4 2017 and held it in 16 quarters.
  • Trilogy Capital's Xerox position peaked at $1.15M in Q4 2021.
  • 324 funds tracked by Wall St. Rank held Xerox as of Q1 2022.

Based on Trilogy Capital's 13F filing for Q1 2022, filed 8 Apr 2022.